MedTrace Logo

3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma

NCT03791944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-02-23

No results posted yet for this study

Summary

Verify that 3DV+TPS is non-inferior compared to existing imported TPS and superior to existing domestic TPS.

Conditions

  • Nasopharynx Cancer
  • Radiotherapy

Interventions

DEVICE

3DV+TPS/VARIAN

Use imported 3DV+TPS to map targets and develop treatment plans

DEVICE

TPS / VARIAN

Use imported TPS to map targets and develop treatment plans

DEVICE

3DV + TPS / Domestic Accelerator

Use domestic 3DV+TPS to delineate target areas and develop treatment plans

DEVICE

TPS / Domestic Accelerator

Use domestic TPS to map targets and develop treatment plans

Sponsors & Collaborators

  • Xinqiao Hospital of Chongqing

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-01-31
Completion
2019-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03791944 on ClinicalTrials.gov